Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy

BACKGROUND: Lenvatinib is a novel tyrosine kinase inhibitor that exhibits an antitumor effect on hepatocellular carcinoma (HCC). An established strategy that involves surgery and usage of lenvatinib for advanced HCC remains elusive. CASE PRESENTATION: A 58-year-old male patient with advanced HCC and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surg Case Rep
Hauptverfasser: Ohya, Yuki, Hayashida, Shintaro, Tsuji, Akira, Kuramoto, Kunitaka, Shibata, Hidekatsu, Setoyama, Hiroko, Hayashi, Hironori, Kuriwaki, Kazumi, Sasaki, Masato, Iizaka, Masayoshi, Nakahara, Osamu, Inomata, Yukihiro
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Berlin Heidelberg 2020
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7728870/
https://ncbi.nlm.nih.gov/pubmed/33301055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-020-01078-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge